Stocktoria
MUSTANG BIO, INC. MBIO
MUSTANG BIO, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| R&D expense | — | — | — | — | — | — | — | $2.1M | $100,000 | $2.0M |
| Operating income | -$2.4M | -$16.2M | -$49.3M | -$76.2M | -$66.7M | -$56.8M | -$45.9M | -$31.2M | -$31.8M | -$11.4M |
| Income tax | $27,000 | — | — | — | — | — | — | — | — | — |
| Net income | -$1.9M | -$15.8M | -$51.6M | -$77.5M | -$66.4M | -$60.0M | -$46.4M | -$30.7M | -$31.3M | -$12.7M |
| EPS (diluted) | $-0.39 | $-38.57 | $-299.95 | $-10.09 | $-0.76 | — | — | — | — | — |
| Operating cash flow | -$5.3M | -$11.4M | -$49.5M | -$65.1M | -$53.7M | -$37.3M | -$33.6M | -$19.2M | -$12.9M | -$4.1M |
| Free cash flow | — | -$11.4M | -$49.5M | -$67.8M | -$57.7M | -$39.2M | -$35.9M | -$26.1M | -$13.4M | — |
| Cash & equivalents | $17.3M | $6.8M | $6.2M | $75.7M | $109.6M | $97.8M | $61.4M | $16.5M | — | $27.5M |
| Total assets | $17.6M | $9.3M | $17.7M | $92.4M | $125.2M | $109.9M | $73.4M | $42.8M | $63.5M | $27.5M |
| Total liabilities | $8.1M | $13.2M | $17.6M | $46.1M | $12.8M | $11.5M | $21.8M | $6.4M | $3.7M | $3.2M |
| Shareholders' equity | $9.5M | -$3.9M | $123,000 | $46.3M | $112.4M | $98.4M | $51.7M | $36.4M | $59.8M | $24.3M |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.